UCLA Hematology/Oncology - Irvine

Clinical research site in Irvine, California

Part of UCLA

As of July 2026, 1 paid clinical trial is recruiting at UCLA Hematology/Oncology - Irvine in Irvine, California. Active studies at this site cover conditions such as Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer and Prostate Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at UCLA Hematology/Oncology - Irvine (1)

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

122 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

More research sites in Irvine

City of Hope at Irvine Lennar (57 trials)
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care (54 trials)
University of California, Irvine (34 trials)
University of California Irvine (19 trials)
Kaiser Permanente-Irvine (18 trials)
City of Hope Orange County Lennar Foundation Cancer Center (10 trials)
City of Hope - Orange County Lennar Foundation Cancer Center (10 trials)
City of Hope (8 trials)
Irvine Clinical Research (6 trials)
Beckman Laser Institute and Medical Clinic (4 trials)

Explore more

Paid clinical trials in Irvine, CA · California clinical trials